Summary:
- The article discusses the use of "supercharged" T cells, a type of immune cell, in the fight against cancer. T cells are being genetically engineered to recognize and attack cancer cells more effectively.
- These modified T cells, called chimeric antigen receptor (CAR) T cells, have shown promising results in clinical trials for various types of cancer, including leukemia, lymphoma, and multiple myeloma.
- The article highlights the potential of CAR T-cell therapy to revolutionize cancer treatment, providing a more targeted and personalized approach compared to traditional therapies like chemotherapy and radiation.